Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rafael Diaz, MD"'
Autor:
John Eikelboom, MBBS, MSc, Sumathy Rangarajan, MSc, Sanjit S. Jolly, MD, Emilie P. Belley-Cote, MD, PhD, Richard Whitlock, MD, PhD, Heather Beresh, MSc, Gayle Lewis, Lizhen Xu, PhD, Noel Chan, MD, Shrikant Bangdiwala, PhD, Rafael Diaz, MD, Andres Orlandini, MD, Mohamed Hassany, MD, Wadea M. Tarhuni, MD, A.M. Yusufali, MD, Sanjib Kumar Sharma, MD, Anna Kontsevaya, PhD, Patricio Lopez-Jaramillo, MD, Alvaro Avezum, MD, Antonio L. Dans, MD, Sean Wasserman, MBChB, Camilo Felix, MD, Khawar Kazmi, MD, Prem Pais, MD, Denis Xavier, MD, Renato D. Lopes, MD, PhD, Otavio Berwanger, MD, Menelas Nkeshimana, MMed, William Harper, MD, Mark Loeb, MD, Shurjeel Choudhri, MD, Michael E. Farkouh, MD, Jackie Bosch, PhD, Sonia S. Anand, PhD, Salim Yusuf, DPhil
Publikováno v:
CJC Open, Vol 4, Iss 6, Pp 568-576 (2022)
Background: Effective treatments for COVID-19 are urgently needed, but conducting randomized trials during the pandemic has been challenging. Methods: The Anti-Coronavirus Therapy (ACT) trials are parallel factorial international trials that aimed to
Externí odkaz:
https://doaj.org/article/585b79616e5942cc97f1ad18f5a15a5f
Autor:
Perry Hystad, PhD, Andrew Larkin, PhD, Sumathy Rangarajan, MSc, Khalid F AlHabib, MBBS, Álvaro Avezum, ProfPhD, Kevser Burcu Tumerdem Calik, MD, Jephat Chifamba, DPhil, Antonio Dans, ProfMD, Rafael Diaz, MD, Johan L du Plessis, PhD, Rajeev Gupta, ProfPhD, Romaina Iqbal, PhD, Rasha Khatib, PhD, Roya Kelishadi, MD, Fernando Lanas, ProfMD, Zhiguang Liu, MPH, Patricio Lopez-Jaramillo, ProfPhD, Sanjeev Nair, MD, Paul Poirier, ProfPhD, Omar Rahman, ProfDSc, Annika Rosengren, ProfMD, Hany Swidan, FRCGP, Lap Ah Tse, PhD, Li Wei, ProfPhD, Andreas Wielgosz, ProfPhD, Karen Yeates, MD, Khalid Yusoff, MBBS, Tomasz Zatoński, PhD, Rick Burnett, PhD, Salim Yusuf, ProfPhD, Michael Brauer, ProfScD
Publikováno v:
The Lancet Planetary Health, Vol 4, Iss 6, Pp e235-e245 (2020)
Summary: Background: Most studies of long-term exposure to outdoor fine particulate matter (PM2·5) and cardiovascular disease are from high-income countries with relatively low PM2·5 concentrations. It is unclear whether risks are similar in low-in
Externí odkaz:
https://doaj.org/article/914381289b814a87808877dc61fce1cd
Autor:
Adrianna Murphy, PhD, Benjamin Palafox, MSc, Owen O'Donnell, ProfPhD, David Stuckler, ProfPhD, Pablo Perel, PhD, Khalid F AlHabib, ProfMBBS, Alvaro Avezum, ProfPhD, Xiulin Bai, BSc, Jephat Chifamba, ProfDPhil, Clara K Chow, ProfPhD, Daniel J Corsi, PhD, Gilles R Dagenais, MD, Antonio L Dans, MD, Rafael Diaz, MD, Ayse N Erbakan, MD, Noorhassim Ismail, MD, Romaina Iqbal, PhD, Roya Kelishadi, MD, Rasha Khatib, PhD, Fernando Lanas, PhD, Scott A Lear, ProfPhD, Wei Li, ProfPhD, Jia Liu, MSc, Patricio Lopez-Jaramillo, ProfPhD, Viswanathan Mohan, ProfMD, Nahed Monsef, PhD, Prem K Mony, MD, Thandi Puoane, ProfDrPH, Sumathy Rangarajan, MSc, Annika Rosengren, ProfMD, Aletta E Schutte, ProfPhD, Mariz Sintaha, MSc, Koon K Teo, ProfPhD, Andreas Wielgosz, ProfMD, Karen Yeates, MD, Lu Yin, PhD, Khalid Yusoff, ProfMBBS, Katarzyna Zatońska, PhD, Salim Yusuf, ProfPhD, Martin McKee, ProfPhD
Publikováno v:
The Lancet Global Health, Vol 6, Iss 3, Pp e292-e301 (2018)
Summary: Background: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. Methods: We assessed use of antiplatelet, choleste
Externí odkaz:
https://doaj.org/article/d48fe3873f824d4ca3b3e34e4f9ab7f6